The present invention is related to dalcetrapib or dalcetrapib-thiol, or a combination thereof for use in the prevention and/or treatment of disorders characterized by inefficient transport and delivery of oxygen to peripheral tissues, in particular sickle cell trait and thalassemia. The invention in particular relates to pharmaceutical formulations, regimens, methods of treatment and uses thereof.
展开▼
